The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ATNF | -51.53% | -99.95% | -78.15% | -100% |
| S&P | +18.37% | +110.18% | +16.02% | +184% |
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | $0.00M | 100.0% |
| Market Cap | $5.61M | 298.4% |
| Market Cap / Employee | $1.87M | 0.0% |
| Employees | 3 | -25.0% |
| Net Income | -$1.73M | -14755.8% |
| EBITDA | -$1.73M | 5.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.22M | 93.5% |
| Accounts Receivable | $0.28M | 0.0% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | -100.0% |
| Short Term Debt | $1.41M | 229.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -125.89% | 16.9% |
| Return On Invested Capital | 3599.74% | -0.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1.13M | -255.5% |
| Operating Free Cash Flow | -$1.13M | -255.5% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.46 | 0.63 | 0.66 | 1.04 | -170.67% |
| Price to Tangible Book Value | -7.93 | -3.39 | 19.11 | 576.25 | -10507.38% |
| Enterprise Value to EBITDA | -2.00 | -0.96 | 0.04 | -2.60 | 482.35% |
| Return on Equity | -174.2% | -135.2% | -221.2% | -371.0% | -6.91% |
| Total Debt | $0.48M | $0.15M | $0.15M | $1.41M | 219.35% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
